Browsing Tag
4D-110
2 posts
Gene therapy company 4D Molecular Therapeutics raises $70m in Series C round
California-based gene therapy company 4D Molecular Therapeutics (4DMT), which is focused on adeno-associated virus (AAV) gene therapy vector…
4D Molecular Therapeutics’ 4D-110 receives FDA orphan drug designation for choroideremia
4D Molecular Therapeutics (4DMT), a prominent California-based gene therapy firm, has achieved a significant milestone with the US…